RxDoctor Payments Data

Adaobi Adimorah

Registered Nurse · Colton, CANPI 1114429719

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 131 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Otsuka America Pharmaceutical, Inc. at 27.9% of the total. 2025 is the largest year on record at $2,038, more than ten times the $125 reported in 2022. Among registered nurse clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,792in general payments, 2019–2025

Across 131 payments — averaging $21.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$779
  • AbbVie$554
  • Johnson & Johnson$316
  • Teva Pharmaceuticals USA, Inc.$307
  • Neurocrine Biosciences, Inc.$256
  • E.r. Squibb & Sons, L.L.C.$131
  • plus $449 from 5 others

What the payments were for

  • Food & beverage$2,792100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,792 in reported general payments places this provider in the 95th percentile of 533 registered nurse providers in California.

See all registered nurse providers in California

Medicare billing

Part B allowed, 2024
$9,054
Medicare patients
33
Services billed
66

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Venlafaxine Hcl ErVenlafaxine Hcl34$1,192
Bupropion XlBupropion Hcl14$589
Olanzapine31$431
Duloxetine Hcl24$426
Mirtazapine25$397
Lamotrigine24$381
Buspirone Hcl37$371
Fluoxetine Hcl29$352
Quetiapine Fumarate33$339
Trazodone Hcl43$317
Aripiprazole18$302
Alprazolam49$266
Bupropion Hcl SrBupropion Hcl19$255
Escitalopram Oxalate39$252
Clonazepam33$237

Paid to pharmacies, not to this prescriber.

Other registered nurse in Colton

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →